Cart
sales@molnova.com
N-Methylbenzamide
CAS No. 613-93-4
N-Methylbenzamide( —— )
Catalog No. M26316 CAS No. 613-93-4
N-Methylbenzamide is a potent phosphodiesterase 10A (PDE10A) inhibitor,with anti-cancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameN-Methylbenzamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Methylbenzamide is a potent phosphodiesterase 10A (PDE10A) inhibitor,with anti-cancer activity.
-
DescriptionN-Methylbenzamide is a potent phosphodiesterase 10A (PDE10A) inhibitor,with anti-cancer activity.(In Vivo):N-Methylbenzamide is active against tumor in donor female BDF mice (18-23 g).
-
In Vitro——
-
In VivoN-Methylbenzamide (compound 21; 100-800 mg/kg; ip; for 17 days) is active against tumor in donor female BDF mice (18-23 g).
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorAntifection| Antifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number613-93-4
-
Formula Weight135.166
-
Molecular FormulaC8H9NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1849.66 mM)
-
SMILESCNC(=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Activity of quinones from teak (Tectona grandis) on fungal cell wall stress.Planta Med. 2006 Aug;72(10):943-4.
molnova catalog
related products
-
MBCQ
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.
-
Vardenafil
Vardenafil (Levitra) is an oral therapy for the treatment of erectile dysfunction.
-
CDP-840
CDP-840 (CDP840;L-765527) is a potent and selective PDE4 inhibitor with IC50 of 4-45 nM for PDE 4 extracted from tissues or recombinant PDE 4 isoforms expressed in yeast.
